CIK 0000874716 · Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010393723
- Phone
- 2075560300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise | +706 | $141.60 | $100K | 11,139 |
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise | +560 | $178.26 | $100K | 11,699 |
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise | +483 | $206.94 | $100K | 12,182 |
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −483 | 0 | ||
| 2026-11-04 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise | +8,906 | $288.78 | $2.6M | 16,074.65 |
| 2026-11-04 | Underberg Sharon E. EVP, GC & Corporate Secretary | Sale | −6,348 | $688.25 | $4.4M | 9,726.65 |
| 2026-11-04 | Underberg Sharon E. EVP, GC & Corporate Secretary | Sale | −1,503 | $689.05 | $1.0M | 8,223.65 |
| 2026-11-04 | Underberg Sharon E. EVP, GC & Corporate Secretary | Sale | −1,055 | $690.02 | $728K | 7,168.65 |
| 2026-11-04 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise · Non-Qualified Stock Option (right-to-buy) | −8,906 | 0 | ||
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Option exercise | +25,140 | $178.26 | $4.5M | 108,943.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −1,945 | $698.26 | $1.4M | 106,998.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −4,075 | $699.33 | $2.8M | 102,923.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −1,667 | $700.33 | $1.2M | 101,256.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −4,540 | $701.36 | $3.2M | 96,716.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −2,136 | $702.21 | $1.5M | 94,580.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −3,950 | $703.45 | $2.8M | 90,630.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −240 | $705.59 | $169K | 90,390.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −840 | $707.00 | $594K | 89,550.3 |
Page 1 of 28 · 552 trades